Clinical Trial Update: Stroke Prevention With Abciximab in Carotid Endarterectomy [Phase 1, Phase 2]

View source ↗

Summary

The University of Rochester's Phase 1/2 trial evaluating Abciximab for stroke prevention during carotid endarterectomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Stenosis

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: University of Rochester | Conditions: Carotid Stenosis | Phase 1, Phase 2 | Status: WITHDRAWN